FDA Gathers Feedback To Guide Oversight Of Lab-Developed Testing

FDA says it will tailor its future oversight of laboratory tests and services based on risk, but experts warn that "high risk" will be hard to define for these diagnostics

More from Archive

More from Medtech Insight